FAIRFIELD, Conn.--(BUSINESS WIRE)--IMS Health (NYSE: RX) today announced expanded capabilities and expertise to demonstrate the health outcomes and economic value of medicines in real-world practice. The company has assembled one of the industry’s largest global teams of Health Economics and Outcomes Research (HEOR) specialists, the broadest and deepest set of information assets, and robust and consistent methodologies to drive healthcare access decisions in an increasingly dynamic environment.
